BeiGene’s Brukinsa Among Nine Drugs To Win EU Marketing Thumbs Up

Tanezumab’s Modest Impact On Osteoarthritis Pain Draws Negative CHMP Opinion

 
• By Vibha Sharma

A number of new medicines are moving closer to the EU market after the European Medicines Agency recommended in favor of their approval. 

3D illustration of files with schizophrenia diagnosis and treatment with antipsychotic medication and psychotherapy.
EMA OKs Longest Available Dosing Interval For An Antipsychotic Medication • Source: Alamy

More from Europe

More from Geography